Genetic Testing
Bacterial Genome Sequencing De Novo Assembly and Annotation Illumina and ONT Hybrid
Bacterial Genome Sequencing De Novo Assembly and Annotation using Illumina and ONT Hybrid provides detailed insights into the genetic makeup of bacteria. This test combines two sequencing technologies for comprehensive analysis, useful for understanding bacterial behavior, resistance, and evolution.
About this service
This service involves sequencing the complete genome of bacteria using a hybrid approach that combines Illumina and Oxford Nanopore Technologies (ONT). The goal is to provide a detailed genetic profile of the bacteria being studied. This information can help identify genetic variations, mutations, and potential antibiotic resistance genes. This test may be considered in situations involving unexplained infections, concerns about antibiotic resistance, the need for precise bacterial identification, or research into bacterial genomics and epidemiology. It aims to offer a deeper understanding of bacterial infections and their mechanisms. The results provide genomic information that can potentially guide treatment decisions and inform public health strategies. The analysis is performed by an expert team, and a comprehensive report is provided. Understanding the implications of the results may require discussion with a healthcare professional.
Service highlights
- Combines Illumina and ONT sequencing technologies for comprehensive analysis.
- Enables identification of genetic variations, mutations, and potential resistance genes.
- Provides detailed insights into bacterial behavior, resistance patterns, and evolutionary trends.
- Aims to support targeted therapy and public health surveillance.
Who may consider it
- Researchers studying bacterial genomics and epidemiology.
- Clinicians dealing with unexplained infections.
- Public health officials investigating outbreaks.
- Healthcare providers concerned about antibiotic resistance.
What to expect
Confirm the specific sample collection requirements, turnaround time, and report format with DNA Labs Kenya before booking. The process involves sequencing bacterial DNA using Illumina and ONT technologies, followed by analysis and reporting.
Scope and limitations
This service sequences and analyzes the bacterial genome using a hybrid Illumina and ONT approach. It identifies genetic variations and potential resistance genes. It does not provide medical advice, diagnosis, or treatment recommendations. The interpretation of results should be done in consultation with a qualified healthcare professional.
Frequently asked questions
What technologies are used in this test?
This test uses a hybrid approach combining Illumina and Oxford Nanopore Technologies (ONT) sequencing.
What kind of information does this test provide?
The test provides detailed genomic information about bacteria, including genetic variations, mutations, and potential resistance genes.
Who might benefit from this test?
Researchers, clinicians, and public health officials may find this test useful for understanding bacterial infections, resistance, and epidemiology.
How are the results delivered?
Results are analyzed by an expert team and delivered in a comprehensive report. Confirm the report format and delivery method with DNA Labs Kenya.
Can this test help with treatment decisions?
The genomic information may potentially guide treatment decisions, but it should be interpreted in consultation with a qualified healthcare professional.
How do I book this test?
Contact DNA Labs Kenya directly via phone or WhatsApp at +254711564616 for booking information and to confirm current procedures.